Akebia Therapeutics, Inc. (AKBA)

1.59 -0.03 (-1.85%) USD  |  NASDAQ  |  Dec 09, 13:42
More

Akebia Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade